Revisiting the case for genetically engineered mouse models in human myelodysplastic syndrome research
about
Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality?Beyond the Niche: Myelodysplastic Syndrome Topobiology in the Laboratory and in the ClinicEstablished and emerging targeted therapies in the myelodysplastic syndromes.The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemiaGEP analysis validates high risk MDS and acute myeloid leukemia post MDS mice models and highlights novel dysregulated pathways.Targeting of the bone marrow microenvironment improves outcome in a murine model of myelodysplastic syndrome.The microenvironment in myelodysplastic syndromes: niche-mediated disease initiation and progression.Unravelling the relevance of CLEC12A as a cancer stem cell marker in myelodysplastic syndrome.A Black Cohosh Extract Causes Hematologic and Biochemical Changes Consistent with a Functional Cobalamin Deficiency in Female B6C3F1/N Mice.Loss of the proteostasis factor AIRAPL causes myeloid transformation by deregulating IGF-1 signaling.Gene dosage effect of CUX1 in a murine model disrupts HSC homeostasis and controls the severity and mortality of MDS.Setd2 deficiency impairs hematopoietic stem cell self-renewal and causes malignant transformation.The H3K4 methyltransferase Setd1b is essential for hematopoietic stem and progenitor cell homeostasis in mice.Abnormal folate metabolism causes age-, sex- and parent-of-origin-specific haematological defects in mice
P2860
Q26746104-520895AA-547B-4D4C-905C-900658026D53Q26752778-A2613C5A-4CA2-43A2-A0C8-0FFF074E3462Q30245476-B601FE81-2AC5-4B84-88C2-C956BF7D9484Q33796552-D8254797-0430-4C0B-90BC-98C4643C97A5Q36507980-BE234F9C-08FC-4B77-90D3-68B148D51111Q36547805-561AFDBC-163E-4B5D-A1F6-DB1153F7C319Q38615755-A3E755B4-7B7A-47A3-9CBF-927D01497424Q40483682-AFBDDA21-545B-443F-BE7C-D6769E3534E3Q47728623-FC9BF212-4898-4276-A309-4002505DECDBQ50236752-9BE15D8E-F931-4F58-AC07-8CAD799B29B8Q51415663-F2E91479-5F67-4886-BBE7-34014829C680Q52659475-7F5F985F-EE96-46DD-A137-9D8097361187Q55437673-D8E0B4AB-8E48-4D94-852F-B44FD1BE7B06Q58775887-9F0C7CD1-50AF-4D9B-9CCC-BFA3B4605069
P2860
Revisiting the case for genetically engineered mouse models in human myelodysplastic syndrome research
description
2015 nî lūn-bûn
@nan
2015 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Revisiting the case for geneti ...... lodysplastic syndrome research
@ast
Revisiting the case for geneti ...... lodysplastic syndrome research
@en
Revisiting the case for geneti ...... lodysplastic syndrome research
@nl
type
label
Revisiting the case for geneti ...... lodysplastic syndrome research
@ast
Revisiting the case for geneti ...... lodysplastic syndrome research
@en
Revisiting the case for geneti ...... lodysplastic syndrome research
@nl
prefLabel
Revisiting the case for geneti ...... lodysplastic syndrome research
@ast
Revisiting the case for geneti ...... lodysplastic syndrome research
@en
Revisiting the case for geneti ...... lodysplastic syndrome research
@nl
P2860
P50
P3181
P1433
P1476
Revisiting the case for geneti ...... lodysplastic syndrome research
@en
P2093
Marsha C Kinney
P2860
P304
P3181
P356
10.1182/BLOOD-2015-01-624239
P407
P577
2015-06-15T00:00:00Z